Welcome to Fierce Biotech's fifth annual layoff tracker, a resource designed to keep pace with the sector's steady stream of ...
With partner Eli Lilly’s help, the radiopharmaceutical drugmaker priced one of the sector’s largest new stock offerings in ...
24/7 Wall St. on MSN
Biotech Could Be One of 2026’s Biggest Winners, and This ETF Is Perfectly Positioned
Biotech investors spent years waiting for the sector to recover from its brutal 2021 peak. That patience is finally paying ...
Investor's Business Daily on MSN
This biotech stock eyes fresh entry with 522% earnings growth seen
Medicine remains one of the most potentially rewarding of all investment areas. And this biotech stock is flirting with a buy ...
For the third year in a row, Fierce Biotech’s Layoff Tracker is topping the tree as the story with the highest number of ...
Investor's Business Daily on MSN
Biotech stocks' dark winter is over. What that means for investors.
The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping ...
A bevy of other companies also brought in money on Thursday, including Alveus Therapeutics, Diagonal Therapeutics, ...
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...
Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...
The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in ...
Explore the Latest Research Peptides from Biotech Labz Supply Sebastopol, United States – January 4, 2026 / Biotech Labz Supply / Biotech Labz Supply has revealed an exciting enhancement of its ...
Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results